Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2003
06/12/2003WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003WO2003047740A2 ENANTIOSELECTIVE TRANSFORMATION OF α,β-UNSATURATED KETONES USING CHIRAL ORGANIC CATALYSTS
06/12/2003WO2003047626A1 Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
06/12/2003WO2003047584A1 Quinoline derivatives
06/12/2003WO2003047581A1 Acetylene derivatives having mglur 5 antagonistic activity
06/12/2003WO2003047577A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
06/12/2003WO2003047569A1 Compositions and methods for inhibiting prenyltransferases
06/12/2003WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003WO2003047516A2 Pyrimidine compounds
06/12/2003WO2003047347A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
06/12/2003WO2002046199A8 Process and ester derivatives useful for preparation of cephalosporins
06/12/2003US20030109706 Serine pretease inhibitors
06/12/2003US20030109703 Antiinflammatory agents; autoimmune disease
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109609 Thioimidazolidine derivatives as light stabilizers for polymers
06/12/2003US20030109578 Treating acute and chronical inflammatory processes in a patent in need thereof which comprises administering to such patent an amount effective therefor of a compound or salt thereof according to claim 1.
06/12/2003US20030109569 Amorphous, pharmaceutically acceptable atorvastatin salts, especially the calcium salt, are prepared from atorvastatin lactone or from a compound of formula (I) mixture of amorphous and crystalline forms of the atorvastatin salt. HMG-CoA
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109550 Substituted indazole compounds for the treatment of inflammation
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109532 Modulators of dopamine neurotransmission
06/12/2003US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/12/2003US20030109497 Novel imidazolidine derivatives, their preparation and their use
06/12/2003CA2469385A1 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
06/12/2003CA2469193A1 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468846A1 Peroxisome proliferator activated receptor agonists
06/12/2003CA2468349A1 Pyrimidine compounds
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317446A1 Oxindole derivatives
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317438A1 Chromanone derivatives
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317432A1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317266A2 Neuroprotective 2-pyridinamine compositions and related methods
06/11/2003EP0956283B1 Substituted phenyltriazolin(thi)ones and their use as herbicides
06/11/2003EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1422850A Fluoro-contained 1H-1,2,3-triazaazole compounds, preparation method thereof and their use
06/10/2003US6576771 Pesticides, herbicides and fungicides
06/10/2003US6576662 Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them
06/10/2003US6576657 Amidino derivatives and their use as thrombin inhibitors
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576647 Anticancer agents; cyclin dependent kinase inhibitors; improved physical properties, storage stability; materials handling
06/10/2003US6576646 Administering cholinesterase inhibitor
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576643 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2232775C Acyl compounds
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045943A1 Quinazoline compounds with therapeutic use
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045941A1 Pyridine and pyrimidine derivatives
06/05/2003WO2003045938A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
06/05/2003WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045909A2 Methods and intermediates for the synthesis of azepines
06/05/2003WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045364A2 Use of quinazolines to treat t-cell mediated diseases
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003004464A3 Heterocyclic amide derivatives and the use thereof as pesticides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105323 Useful as drug for allergic diseases and autoimmune diseases such as systemic lupus erythemathosus; 2-amino-4-(substituted amino)pyrimidine derivatives; suppression of type 2 helper T cell (Th2) immune responses
06/05/2003US20030105149 Enhancement of learning and memory and treatment of amnesia
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105119 For therapy of inflammation, immune disorders, asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), inflammatory bowel disease (IBD); side effect reduction
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 694